Incorporated in September 2015.
Our mission is:
- Development of complex dosage forms enabling Generic Drugs Early Market Entry
- Development of innovative SuperGeneric products
- Licensing-out to leading Pharma partners world-wide for market access
Phargentis SA
We develop complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products.We deal with licensing-out to leading Pharma partners worldwide for market access.
Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland.
Activities
Main Activity
Licensing-In (Partial)
Licensing-Out
Development
Co-development
Drug Product CMO
Drug development
Drug commercialization
Therapeutic Areas
Respiratory
Markets
CH
EU Top 5
Rest of Europe
USA and Canada
Japan
LATAM
MENA
BRICS
ASEAN
Australia
Other market
Drug Stages
Pre-clinical
Clinical Phase I/Phase III
Phase I - Phase III
Registration
Market
Generic Plus (505B2)
Generic
Life cycle management
Drug Product Forms
Aerosol
Inhaler
Spray
Certifications
Swissmedic
GMP
ISO 13485
